569 related articles for article (PubMed ID: 29787841)
1. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
[TBL] [Abstract][Full Text] [Related]
2. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
[TBL] [Abstract][Full Text] [Related]
3. Atypical fibroxanthoma: Systematic review and meta-analysis of treatment with Mohs micrographic surgery or excision.
Tolkachjov SN; Kelley BF; Alahdab F; Erwin PJ; Brewer JD
J Am Acad Dermatol; 2018 Nov; 79(5):929-934.e6. PubMed ID: 29981390
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.
Roland CL; May CD; Watson KL; Al Sannaa GA; Dineen SP; Feig R; Landers S; Ingram DR; Wang WL; Guadagnolo BA; Feig B; Hunt KK; Cormier JN; Lazar AJ; Torres KE
Ann Surg Oncol; 2016 Jul; 23(7):2220-8. PubMed ID: 26847678
[TBL] [Abstract][Full Text] [Related]
5. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.
Vodanovich DA; Spelman T; May D; Slavin J; Choong PFM
ANZ J Surg; 2019 Sep; 89(9):1045-1050. PubMed ID: 31364245
[TBL] [Abstract][Full Text] [Related]
6. MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities -- an analysis of 140 patients.
Lehnhardt M; Daigeler A; Homann HH; Schwaiberger V; Goertz O; Kuhnen C; Steinau HU
Langenbecks Arch Surg; 2009 Mar; 394(2):313-20. PubMed ID: 18584203
[TBL] [Abstract][Full Text] [Related]
7. Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.
Soleymani T; Aasi SZ; Novoa R; Hollmig ST
Dermatol Clin; 2019 Jul; 37(3):253-259. PubMed ID: 31084719
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive factors in undifferentiated pleomorphic sarcoma: A long-term study from a large tertiary care urban center.
Gonzalez MR; Clunk MJ; Bedi ADS; Werenski JO; Lang JH; Karczewski D; Sodhi A; Lozano-Calderon SA
J Surg Oncol; 2023 Aug; 128(2):322-331. PubMed ID: 37042427
[TBL] [Abstract][Full Text] [Related]
9. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous undifferentiated pleomorphic sarcoma is a pleomorphic dermal sarcoma.
Cohen PR
Dermatol Online J; 2020 May; 26(5):. PubMed ID: 32621710
[TBL] [Abstract][Full Text] [Related]
11. Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative.
Makris EA; Tran TB; Delitto DJ; Lee B; Ethun CG; Grignol V; Harrison Howard J; Bedi M; Clark Gamblin T; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Cardona K; Poultsides G; Kirane A
J Surg Oncol; 2024 Jun; 129(7):1354-1363. PubMed ID: 38562002
[TBL] [Abstract][Full Text] [Related]
12. Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions.
Dineen SP; Roland CL; Feig R; May C; Zhou S; Demicco E; Sannaa GA; Ingram D; Wang WL; Ravi V; Guadagnolo A; Lev D; Pollock RE; Hunt K; Cormier J; Lazar A; Feig B; Torres KE
Ann Surg Oncol; 2015 Nov; 22(12):3913-20. PubMed ID: 25743327
[TBL] [Abstract][Full Text] [Related]
13. MFH and high-grade undifferentiated pleomorphic sarcoma-what's in a name?
Delisca GO; Mesko NW; Alamanda VK; Archer KR; Song Y; Halpern JL; Schwartz HS; Holt GE
J Surg Oncol; 2015 Feb; 111(2):173-7. PubMed ID: 25219789
[TBL] [Abstract][Full Text] [Related]
14. [Atypical fibroxanthoma and pleomorphic dermal sarcoma].
Ziemer M; Jäger IM; Dippel E
Hautarzt; 2019 Sep; 70(9):661-669. PubMed ID: 31468069
[TBL] [Abstract][Full Text] [Related]
15. Pleomorphic Dermal Sarcoma.
Saleh JS; Whittington CP; Bresler SC; Patel RM
Surg Pathol Clin; 2024 Mar; 17(1):153-158. PubMed ID: 38278604
[TBL] [Abstract][Full Text] [Related]
16. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
Soleymani T; Tyler Hollmig S
Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of microscopic tumor extension in local recurrence of myxofibrosarcoma and undifferentiated pleomorphic sarcoma.
Song B; Lee K; Lee C; Moon KC
Pathol Int; 2018 Sep; 68(9):509-516. PubMed ID: 30094896
[TBL] [Abstract][Full Text] [Related]
18. The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University.
Kamat NV; Million L; Yao DH; Donaldson SS; Mohler DG; van de Rijn M; Avedian RS; Kapp DS; Ganjoo KN
Am J Clin Oncol; 2019 Feb; 42(2):166-171. PubMed ID: 30557163
[TBL] [Abstract][Full Text] [Related]
19. Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.
Lewin J; Garg S; Lau BY; Dickson BC; Traub F; Gokgoz N; Griffin AM; Ferguson PC; Andrulis IL; Sim HW; Kamel-Reid S; Stockley TL; Siu LL; Wunder JS; Razak ARA
Int J Cancer; 2018 Jan; 142(1):57-65. PubMed ID: 28891048
[TBL] [Abstract][Full Text] [Related]
20. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
